Richard Aplenc, MD, PhD, MSCE

faculty photo
Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
CTRB Room 4018
3501 Civic Center Blvd
Philadelphia, PA 19104
Office: 2674267252
Education:
A.B. (Classics)
Princeton University, 1988.

University of Pennsylvania, Post-Baccalaureate Pre-Health Program, 1989.
MD
University of Virginia, 1994.
MSCE (Clinical Epidemiology and Biostatistics)
University of Pennsylvania, 2002.
PhD (Epidemiology)
University of Pennsylvania, 2011.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Szymczak, J. E., Getz, K. D., Madding, R., Fisher, B., Raetz, E., Hijiya, N., Gramatges, M. M., Henry, M., Mian, A., Arnold, S. D., Aftandilian, C., Collier, A. B., Aplenc, R.: Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemia. Pediatr Blood Cancer 65(4), 2018.

Bride, K. L., Vincent, T. L., Im, S. Y., Aplenc, R., Barrett, D. M., Carroll, W. L., Carson, R., Dai, Y., Devidas, M., Dunsmore, K. P., Fuller, T., Glisovic-Aplenc, T., Horton, T. M., Hunger, S. P., Loh, M. L., Maude, S. L., Raetz, E. A., Winter, S. S., Grupp, S. A., Hermiston, M. L., Wood, B. L., Teachey, D. T.: Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia. Blood 131(9): 995-999, 2018.

Citrin, R., Getz, K. D., Li, Y., Huang, Y. S., Horowitz, J. P., Seif, A. E., Fisher, B. T., Aplenc, R.: The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non-Hodgkin lymphoma. Br J Haematol 2018.

DiNofia, A. M., Seif, A. E., Devidas, M., Li, Y., Hall, M., Huang, Y. V., Cahen, V., Hunger, S. P., Winick, N. J., Carroll, W. L., Fisher, B. T., Larsen, E. C., Aplenc, R.: Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232. Cancer Med 7(1): 3-12, 2018.

Fitzgerald, J. C., Li, Y., Fisher, B. T., Huang, Y. S., Miller, T. P., Bagatell, R., Seif, A. E., Aplenc, R., Thomas, N. J.: Hospital Variation in Intensive Care Resource Utilization and Mortality in Newly Diagnosed Pediatric Leukemia. Pediatr Crit Care Med 2018.

Getz, K. D., He, C., Li, Y., Huang, Y. V., Burstein, D. S., Rossano, J., Aplenc, R.: Successful merging of data from the United Network for Organ Sharing and the Pediatric Health Information System databases. Pediatr Transplant Page: e13168, 2018.

Getz, K. D., Miller, T. P., Seif, A. E., Li, Y., Huang, Y. V., Fisher, B. T., Aplenc, R.: Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia. PLoS One 13(2): e0192529, 2018.

Lamba, J. K., Voigt, A. P., Chauhan, L., Shin, M., Aplenc, R., Eidenschink Brodersen, L., Gamis, A. S., Meshinchi, S., Loken, M. R.: CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients. Leuk Lymphoma Page: 1-4, 2018.

Brodersen, L. E., Alonzo, T. A., Gerbing, R. B., Kolb, E. A,, Gamis, A. S., Aplenc, R., Meshinchi, S., Loken, M. R.: Clinical Implications of Detection and Clearance of Post-Induction Residual Disease in 2119 Children and Young Adults with AML: Children''s Oncology Group Studies AAML0531 and AAML1031. Blood 130(Suppl 1): 3905-3905, 2017.

Chauhan, L., Alonzo, T. A., Wang, J., Loken, M. R., Pollard, J. A., Aplenc, R., Raimondi, S. C., Walter, R. B., Hirsch, B. A., Bernstein, I. D., Gamis, A. S, Meshinchi, S., Lamba, J.: Drug Transporter ABCB1 SNP Predicts Outcome in Patients with Acute Myeloid Leukemia Treated with Gemtuzumab Ozagamicin: A Report from Children''s Oncology Group AAML0531 Trial. Blood 130(Suppl 1): 2526-2526, 2017.

back to top
Last updated: 04/22/2018
The Trustees of the University of Pennsylvania